论文部分内容阅读
近日,来自英国的科学家他们发现服用格列酮类抗糖尿病药物(罗格列酮或吡格列酮)的糖尿病病人患帕金森病的风险比服用其他类抗糖尿病药物的糖尿病病人低28%。相关研究发表在国际学术期刊plos medicine上。(源自:药品资讯网)
Recently, scientists from Britain found that diabetic patients taking glitazone-type anti-diabetic drugs (rosiglitazone or pioglitazone) had a 28% lower risk of developing Parkinson’s disease than those taking other anti-diabetic drugs. Relevant research published in the international academic journal plos medicine. (From: Drug Information Network)